Abstract
Prepulse inhibition of startle (‘PPI’), a cross-species measure of sensorimotor gating, is impaired in schizophrenia patients. Suppression of P50 event-related potentials (ERPs) in response to the second of two clicks (‘P50 gating’) is also impaired in schizophrenia. Suppression of N40 ERPs to the second of two clicks (‘N40 gating’) is thought by some to be a rat homolog of human P50 gating. Emerging evidence suggests differences in the neurobiology of deficits detected by PPI vs P50 (or N40) gating. We recorded PPI and N40 gating contemporaneously in rats, to assess convergence and divergence in the neurochemical regulation of these measures. Dose–response studies examined the effects of apomorphine (APO), phencyclidine (PCP) or the 5HT2A agonist DOI on PPI, and on motor responses to stimuli (S1 and S2) that elicit N40 gating. Effects of optimal drug doses on PPI and N40 gating were then assessed in other rats with implanted cortical surface electrodes. APO, PCP and DOI caused dose-dependent disruptions of both PPI and gating of motor responses to N40 stimuli. Reduced PPI reflected diminished prepulse effectiveness, demonstrated by increased startle levels on prepulse+pulse trials. In contrast, reduced gating of motor responses to N40 stimuli reflected a reduced motor response to S1. In separate rats, robust PPI, N40 potentials and N40 gating could be detected within one test. PPI and N40 gating were disrupted by APO, PCP, and DOI. Again, drug effects on PPI reflected increased startle on prepulse+pulse trials, while those on N40 gating reflected reduced ERP responses to S1. In conslusion, when PPI and N40 gating were studied concurrently in rats, drug effects on PPI reflected reduced inhibition of startle by the prepulse, while diminished N40 gating reflected S1 response suppression. Despite similarities in drug sensitivity, these results suggest that distinct neurobiological mechanisms underlie drug-induced deficits in PPI and N40 gating.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Adams CE, Stevens KE (1998). Inhibition of nitric oxide synthase disrupts inhibitory gating of auditory responses in rat hippocampus. J Pharmacol Exp Ther 287: 760–765.
Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R (1982). Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17: 639–654.
Adler LE, Rose G, Freedman R (1986). Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol. Biol Psychiatry 21: 787–798.
Bolino F, DiMichele V, DiCicco L, Manna V, Daneluzzo E, Casacchia M (1994). Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia. Biol Psychiatry 36: 670–679.
Boutros NN, Korzyukov O, Jansen B, Feingold A, Bell M (2004). Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res 126: 203–215.
Boutros NN, Uretsky N, Berntson G, Bornstein R (1994). Effects of cocaine on sensory inhibition in rats: preliminary data. Biol Psychiatry 36: 242–248.
Boutros NN, Zouridakis G, Overall J (1991). Replication and extension of P50 findings in schizophrenia. Clin Electroencephalogr 22: 40–45.
Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978). Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 14: 339–343.
Braff DL, Freedman R (2002). The importance of endophenotypes in studies of the genetics of schizophrenia. Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Baltimore, MD. pp 703–716.
Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KC et al (2001a). Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 49: 171–178.
Braff DL, Geyer MA, Swerdlow NR (2001b). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156: 234–258.
Braff DL, Swerdlow NR, Geyer MA (1999). Symptom correlates of prepulse inhibition deficits in male schizophrenia patients. Am J Psychiatry 156: 596–602.
Brenner CA, Edwards CR, Carroll CA, Kieffaber PD, Hetrick WP (2004). P50 and acoustic startle gating are not related in healthy participants. Psychophysiology 41: 702–708.
Cadenhead KS, Light GA, Geyer MA, Braff DL (2000a). Sensory gating deficits assessed by the P50 event-related-potential in subjects with schizotypal personality disorder. Am J Psychiatr 157: 55–59.
Cadenhead KS, Light GA, Geyer MA, McDowell JE, Braff DL (2002). Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype? Am J Psychiatr 159: 869–871.
Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL (2000b). Modulation of the startle response and startle laterality in relatives of schizophrenia patients and schizotypal personality disordered subjects: evidence of inhibitory deficits. Am J Psychiatr 157: 1660–1668.
Clementz BA, Geyer MA, Braff DL (1998). Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatr 155: 1691–1694.
de Bruin NM, Ellenbroek BA, Cools AR, Coenen AM, van Luijtelaar EL (1999). Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats. Psychopharmacology 142: 9–17.
de Bruin NM, Ellenbroek BA, van Luijtelaar EL, Cools AR, Stevens KE (2001a). Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell. Neuroscience 105: 169–180.
de Bruin NM, van Luijtelaar EL, Cools AR, Ellenbroek BA (2001b). Auditory information processing in rat genotypes with different dopaminergic properties. Psychopharmacology 156: 352–359.
Ellenbroek BA, van Luijtelaar G, Frenken M, Cools AR (1999). Sensory gating in rats: lack of correlation between auditory evoked potential gating and prepulse inhibition. Schizophr Bull 25: 777–788.
Erwin RJ, Turetsky BI, Moberg P, Gur RC, Gur RE (1998). P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophr Res 33: 157–167.
Freedman R, Adler LE, Gerhardt GA, Waldo M, Baker N, Rose GM et al (1987). Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull 13: 669–678.
Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD (1983). Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol Psychiatry 18: 537–551.
Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A et al (1997). Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94: 587–592.
Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156: 117–154.
Geyer MA, Swerdlow NR (1998). The startle reflex and its use in preclinical measures of sensorimotor gating. In: Crawley JN, Skolnick P (eds). Current Protocols in Neuroscience. John Wiley & Sons: New York, 8.7.1–8.7.15.
Graham F (1975). The more or less startling effects of weak prestimuli. Psychophysiology 12: 238–248.
Grunwald T, Boutros NN, Pezer N, von Oertzen J, Fernandez G, Schaller C et al (2003). Neuronal substrates of sensory gating within the human brain. Biol Psychiatr 53: 511–519.
Johnson RG, Stevens KE, Rose GM (1998). 5-Hydroxytryptamine2 receptors modulate auditory filtering in the rat. J Pharmacol Exp Ther 285: 643–650.
Judd LL, McAdams L, Budnick B, Braff DL (1992). Sensory gating deficits in schizophrenia: new results. Am J Psychiatr 149: 488–493.
Kumari V, Soni W, Sharma T (1999). Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatr 156: 1046–1051.
Light GA, Braff DL (2001). Measuring P50 suppression and prepulse inhibition in a single recording session. Am J Psychiatr 158: 2066–2068.
Light GA, Braff DL (2005). Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatr 62: 127–136.
Ludewig K, Geyer MA, Etzensberger M, Vollenweider FX (2002). Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia. Schizophr Res 55: 129–137.
Mansbach RS, Geyer MA (1989). Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2: 299–308.
Maxwell CR, Liang Y, Weightman BD, Kanes SJ, Abel T, Gur RE et al (2004). Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential. Neuropsychopharmacology 29: 739–746.
Miller CL, Bickford PC, Luntz-Leybman V, Adler LE, Gerhardt GA, Freedman R (1992). Phencyclidine and auditory sensory gating in the hippocampus of the rat. Neuropharmacology 31: 1041–1048.
Miyazato H, Skinner RD, Garcia-Rill E (1999). Sensory gating of the P13 midlatency auditory evoked potential and the startle response in the rat. Brain Res 822: 60–71.
Myles-Worsley M (2002). P50 sensory gating in multiplex schizophrenia families from a Pacific island isolate. Am J Psychiatry 159: 2007–2012.
Nagamoto HT, Adler LE, Waldo MC, Freedman R (1989). Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol Psychiatry 25: 549–561.
Oranje B, van Berckel BN, Kemmer C, van Ree JM, Kahn RS, Verbaten MN (1999). P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study. Biol Psychiatry 45: 883–890.
Oranje B, van Oel CJ, Gispen-De Wied CC, Verbaten MN, Kahn RS (2002). Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol 22: 359–365.
Parwani A, Duncan EJ, Bartlett E, Madonick SH, Efferen TR, Rajan R et al (2000). Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 47: 662–669.
Schwarzkopf SB, Lamberti JS, Smith DA (1993). Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition. Biol Psychiatry 33: 815–828.
Shepard PD, Joy B, Clerkin L, Schwarcz R. (2003). Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat. Neuropsychopharmacology 28: 1454–1462.
Siegel C, Waldo M, Mizner G, Adler LE, Freedman R (1984). Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch Gen Psychiatr 41: 607–612.
Sipes TE, Geyer MA (1994). Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33: 441–448.
Stevens KE, Fuller LL, Rose GM (1991). Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res 555: 91–98.
Stevens KE, Luthman J, Lindqvist E, Johnson RG, Rose GM (1996). Effects of neonatal dopamine depletion on sensory inhibition in the rat. Pharmacol Biochem Behav 53: 817–823.
Stevens KE, Meltzer J, Rose GM (1995). Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats. Psychopharmacology 119: 163–170.
Stevens KE, Nagamoto H, Johnson RG, Adams CE, Rose GM (1998). Kainic acid lesions in adult rats as a model of schizophrenia: changes in auditory information processing. Neuroscience 82: 701–708.
Swerdlow NR, Bongiovanni MJ, Tochen LS, Shoemaker JM (2005). Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: Implications for predictive validity and Tourette Syndrome. Abstr Soc Biol Psychiatry 57: 39S.
Swerdlow NR, Braff DL, Geyer MA (2000). Animal models of deficient sensorimotor gating: What we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11: 185–204.
Swerdlow NR, Geyer M, Braff D, Koob GF (1986). Central dopamine hyperactivity in rats mimics abnormal acoustic startle in schizophrenics. Biol Psychiatry 21: 23–33.
Swerdlow NR, Geyer MA, Braff DL (2001a). Neural circuitry of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156: 194–215.
Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach P (2001b). Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology 158: 230–240.
Waldo MC, Adler LE, Freedman R (1988). Defects in auditory sensory gating and their apparent compensation in relatives of schizophrenics. Schiz Res 1: 19–24.
Wan FJ, Taaid N, Swerdlow NR (1996). Do D1/D2 interactions regulate prepulse inhibition in rats? Neuropsychopharmacology 14: 265–274.
Weike AI, Bauer U, Hamm AO (2000). Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry 47: 61–70.
Acknowledgements
This work was supported by MH01436 and MH53484 (NRS) and MH42228 (DLB, NRS, MAG, KES). MAG holds an equity interest in San Diego Instruments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Swerdlow, N., Geyer, M., Shoemaker, J. et al. Convergence and Divergence in the Neurochemical Regulation of Prepulse Inhibition of Startle and N40 Suppression in Rats. Neuropsychopharmacol 31, 506–515 (2006). https://doi.org/10.1038/sj.npp.1300841
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300841
Keywords
This article is cited by
-
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity
Forensic Toxicology (2019)
-
Differential effects of estrogen and testosterone on auditory sensory gating in rats
Psychopharmacology (2014)
-
Mutual independence of 5-HT2 and α1 noradrenergic receptors in mediating deficits in sensorimotor gating
Psychopharmacology (2012)
-
Early Auditory Sensory Processing Deficits in Mouse Mutants with Reduced NMDA Receptor Function
Neuropsychopharmacology (2008)
-
Differential Effects of Acute Serotonin and Dopamine Depletion on Prepulse Inhibition and P50 Suppression Measures of Sensorimotor and Sensory Gating in Humans
Neuropsychopharmacology (2008)
